Tag: TGen
Carcinoid Cancer Foundation Presents Symposium on Cutting-Edge Treatment
March 23, 2010
Determining Molecular Signature: A Guide for Targeted Therapy of Neuroendocrine Tumors
Imagine a treatment created just for you as a carcinoid or other neuroendocrine tumor patient based upon a personalized genomic analysis. This is the cutting-edge…
READ MORE
Steve Jobs, Pancreatic Neuroendocrine Tumor Patient, Talks about Liver Transplant
March 21, 2010
Steve Jobs, CEO of Apple, is the most well-known member of the carcinoid and neuroendocrine tumor community. He was diagnosed with an islet cell pancreatic neuroendocrine tumor (NET) in 2004 for which he had surgery, followed by a liver transplant in …
READ MORE
